Epirubicin/vinorelbine as first line therapy in metastatic breast cancer

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Optimal two-stage designs for phase II clinical trials

1989 • 3,494 citations

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

1996 • 754 citations

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1995 • 563 citations

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.

1995 • 415 citations

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.

1993 • 333 citations

Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic

1996 • 243 citations

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group.

1988 • 176 citations

Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group.

1996 • 175 citations

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.

1988 • 167 citations

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.

1994 • 144 citations

Phase-II study of Navelbine in advanced breast cancer.

1989 • 132 citations

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

1994 • 110 citations

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.

1994 • 102 citations

Dose-finding study and pharmacokinetics of epirubicin and paclitaxel over 3 hours: a regimen with high activity and low cardiotoxicity in advanced breast cancer.

1997 • 91 citations

Systemic Therapy of Advanced Breast Cancer

1992 • 81 citations

Phase I pharmacologic study of a new Vinca alkaloid: Navelbine

1985 • 80 citations

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer.

1996 • 52 citations

The Current and Future Place of Vinorelbine in Cancer Therapy

1992 • 48 citations

Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study

1995 • 17 citations

Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer

1993 • 16 citations

Systemic Therapy of Metastatic Breast Cancer

1990 • 1 citations